Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping



Papaxoinis, George and Kotoula, Vassiliki and Giannoulatou, Eleni and Koliou, Georgia-Angeliki and Karavasilis, Vasilios and Lakis, Sotirios and Koureas, Andreas and Bobos, Mattheos and Chalaralambous, Elpida and Daskalaki, Emily and Chatzopoulos, Kyriakos and Tsironis, George and Pazarli, Elisavet and Chrisafi, Sofia and Samantas, Epaminontas and Kaklamanos, Ioannis G. and Varthalitis, Ioannis and Konstantara, Athina and Syrigos, Konstantinos N. and Pentheroudakis, George and Pectasides, Dimitrios and Fountzilas, George (2018) Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Medical Oncology, 35 (7). p. 101. ISSN 1357-0560 (Not OA)

Link to published document: http://doi.org/10.1007/s12032-018-1160-1

Abstract

Metadata

Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 04 Jun 2018 22:55
Last Modified: 04 Dec 2018 03:28